Anti-counterfeiting treaty could "kill" patients, European Commission meeting hears
This article was originally published in Scrip
Executive Summary
The European Commission defended itself rigorously this week against detractors on the controversial multilateral Anti-Counterfeiting Trade Agreement (ACTA), which is looking to strengthen the enforcement of intellectual property rights (IPRs) and combat counterfeiting and piracy.